Pharma

Apr 7 2018

Aerie swoops on DSM tech for eye disease candidates, FierceBiotech, dsm pharmaceuticals.#Dsm #pharmaceuticals

Aerie swoops on DSM tech for eye disease candidates Aerie Pharma—just months away from a possible approval for its lead glaucoma drug—is hoping to unlock the potential of a key pipeline compound with help from Netherlands company Royal DSM. Irvine-based Aerie thinks that a polymer implant technology developed by DSM could make the difference to AR-13154, a Rho kinase (ROCK) and protein kinase C (PKC) inhibitor that has shown promise in preclinical studies as a treatment for wet age-related macular degeneration, a leading cause of sight loss. Aerie says AR-13154 has matched VEGF inhibitors such as Novartis’ blockbuster Lucentis (ranibizumab) …

Jan 8 2018

Patheon and DSM complete $ merger to form private company DPx #pharmaceutical #companies #in #chicago

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Jan 8 2018

Dsm pharma #pharma #market #research

#dsm pharma # DSM/Patheon Deal Hits 3 NC Regions Massive DSM manufacturing campus in Greenville. Courtesy of DSM Pharmaceutical workers in North Carolina’s three leading life science regions are hopeful that an unfolding corporate transformation will bode well for job retention – and possible expansion. The Dutch parent company of DSM Pharmaceuticals. whose Greenville factory is the largest contract manufacturing facility in North America, is merging with Patheon. the Durham-based company that bought Banner Pharmacaps in High Point for $255 million in December 2012. The name of the new post-merger global pharma company has not yet been made public. Corporate …

Dec 25 2017

DSM says plans to cut 1, 100 jobs prompted by recent pharma moves not shareholder pressure #biotech #pharma

#dsm pharma # DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure By Gareth MacDonald+ Gareth MACDONALD 25-Aug-2015 2015-08-25T00:00:00Z Last updated on 26-Aug-2015 at 13:46 GMT 2015-08-26T13:46:47Z Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. DSM said around half of the job cuts will be at …

Nov 30 2017

DSM on the Forbes Global 2000 List #pharmaceutical #drug #companies

#dsm pharma # #1 287 DSM Market Cap As of May 2016 $10.3 Billion Industry Diversified Chemicals Founded 1902 Country Netherlands Chief Executive Officer Feike Sijbesma Website http://www.dsm.com Employees 20 750 Sales $8.56 B Headquarters Heerlen Royal DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company operates through the following segments: Nutrition, Performance Materials, Pharma, Polymer Intermediates, Innovation Center, and Corporate Activities. The Nutrition segment comprises of the DSM Nutritional Products and DSM Food Specialties business groups, which concentrate on human nutrition and animal nutrition health. The Pharma segment develops and …

Nov 23 2017

DSM says plans to cut 1, 100 jobs prompted by recent pharma moves not shareholder pressure #euro #pharma

#dsm pharma # DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure By Gareth MacDonald+ Gareth MACDONALD 25-Aug-2015 2015-08-25T00:00:00Z Last updated on 26-Aug-2015 at 13:46 GMT 2015-08-26T13:46:47Z Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. DSM said around half of the job cuts will be at …

Nov 23 2017

Patheon and DSM complete $ merger to form private company DPx #avalon #pharma

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Nov 14 2017

DSM on the Forbes Global 2000 List #pharma #rep #jobs

#dsm pharma # #1 287 DSM Market Cap As of May 2016 $10.3 Billion Industry Diversified Chemicals Founded 1902 Country Netherlands Chief Executive Officer Feike Sijbesma Website http://www.dsm.com Employees 20 750 Sales $8.56 B Headquarters Heerlen Royal DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company operates through the following segments: Nutrition, Performance Materials, Pharma, Polymer Intermediates, Innovation Center, and Corporate Activities. The Nutrition segment comprises of the DSM Nutritional Products and DSM Food Specialties business groups, which concentrate on human nutrition and animal nutrition health. The Pharma segment develops and …

Oct 4 2017

Patheon and DSM complete $ merger to form private company DPx #pharmaceutical #company

#dsm pharma # Patheon and DSM complete $2.65bn merger to form private company ‘DPx’ By Dan Stanton+ Dan Stanton 12-Mar-2014 2014-03-12T00:00:00Z Last updated on 12-Mar-2014 at 09:49 GMT 2014-03-12T09:49:12Z Patheon has merged with Royal DSM’s pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world’s second biggest CMO. Plans for the merger were announced in November last year, but the deal only completed yesterday. Under the new structure Patheon’s owner JLL Holdings has a 51% share in DPx with Royal DSM who controlling the remaining 49%. The new company will consist of …

Sep 6 2017

Dsm pharma #pharma #agencies

#dsm pharma # DSM/Patheon Deal Hits 3 NC Regions Massive DSM manufacturing campus in Greenville. Courtesy of DSM Pharmaceutical workers in North Carolina’s three leading life science regions are hopeful that an unfolding corporate transformation will bode well for job retention – and possible expansion. The Dutch parent company of DSM Pharmaceuticals. whose Greenville factory is the largest contract manufacturing facility in North America, is merging with Patheon. the Durham-based company that bought Banner Pharmacaps in High Point for $255 million in December 2012. The name of the new post-merger global pharma company has not yet been made public. Corporate …